JENNA BROWN: Open Payments
NPI 1104292853 · LADY LAKE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 27 payments from 10 companies in 2025. Trend: 2023 $564 · 2024 $556 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $137 |
| Exact Sciences Corporation | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 3 | $59 |
| ABBVIE INC. | 2 | $56 |
| Eisai Inc. | 2 | $53 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PFIZER INC. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, LEQVIO, The Cologuard Plus Collection Kit, VRAYLAR, Leqembi, Wegovy, MOUNJARO, JARDIANCE.
Industry payments across FL — which companies pay providers there.
